Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Hospitals, Device Industry Spar On OPPS “C” Codes Debate; CMS To Referee

This article was originally published in The Gray Sheet

Executive Summary

The American Hospital Association's contention that CMS should not reinstate "C" codes for device-tracking purposes under the hospital OPPS pits the organization against the device industry

You may also be interested in...



CMS To “Systematically Approach” OPPS Multiple-Procedure Discount Policy

Medronic's Activa bilateral stimulation therapy for Parkinson's disease no longer will be subject to CMS' multiple-procedure discount policy, according to the 12004 hospital OPPS final rule

2004 Hospital Outpatient Prospective Payment System Final Rule In Brief

CMS to consider APC Advisory Panel scheduling concerns: Panel members' receipt of device-related materials before their Aug. 22 meeting compensates for the one-hour time period devoted to device issues, according to the Nov. 7 1OPPS final rule. CMS maintains it provided ample notice by first announcing the meeting date July 25 and placing the proposed rule on display Aug. 6 - early enough for a wealth of "thoughtful comments" from "interested parties" to be presented. The explanation responds to device industry criticism that the meeting was held too soon after publication of the Aug. 12 proposed rule (2"The Gray Sheet" Oct. 6, 2003, p. 8). Nonetheless, CMS will "take this comment into consideration"...

CMS To “Systematically Approach” OPPS Multiple-Procedure Discount Policy

Medronic's Activa bilateral stimulation therapy for Parkinson's disease no longer will be subject to CMS' multiple-procedure discount policy, according to the 12004 hospital OPPS final rule

Related Content

UsernamePublicRestriction

Register

ID1132679

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel